NCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
Clinical Trials
8 trialsNCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT03682276 2022-12-13
PRIME-HCC
Imperial College London
Phase 1/2 Unknown
NCT04575922 2022-09-08
Nivolumab+Ipilimumab+RT in MSS mCRC
Massachusetts General Hospital
Phase 2 Unknown
NCT02948348 2021-09-16
Study to Nivolumab Following Preoperative Chemoradiotherapy
National Cancer Center Hospital East
Phase 1/2 Unknown
NCT03784040 2019-04-08
da VINci
National University Hospital, Singapore
Phase 1 Unknown
NCT02982486 2017-11-01
A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT03098160 2017-10-30
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
Phase 1 Unknown